Human DLC3 and Drosophila Cv-c function in testis development: using a model organism to analyse variations in sex development
- Centro Andaluz de Biología del Desarrollo, Spain
- University of Fribourg, Switzerland
- National Academy of Sciences of Ukraine, Ukraine
- University of Geneva, Switzerland
Abstract
Background: The identification of genes affecting gonad development is essential to understand the mechanisms causing Variations/Differences in Sex Development. Recently, a DLC3 mutation was associated with male gonadal dysgenesis in 46,XY DSD patients.
Methods: We have studied the requirement of cv-c, the Drosophila ortholog of DLC3, for Drosophila gonad development as well as the functional capacity of DLC3 human variants to rescue cv-c gonad defects. We show that Cv-c is required to maintain testis integrity during fly development.
Results: We find that Cv-c and human DLC3 can perform the same function in fly embryos, as flies carrying wild type but not patient DLC3 variations can rescue gonadal dysgenesis, suggesting a functional conservation. Expression of different Cv-c protein variants demonstrate that the StART domain mediates Cv-c's function in the male gonad independently from the GAP domain's activity.
Conclusions: This work demonstrates a role for DLC3/Cv-c in male gonadogenesis and highlights a novel StART domain mediated function required to organize the gonadal mesoderm and maintain its interaction with the germ cells during testis development.
Funding: María de Maeztu Unit excellence grants MDM-2016-0687 and CEX-2020-001088-M. Ministerio de Ciencia e Innovación grant PID2019-104656GB-I00 cofunded by the European Regional Development Fund (FEDER). Swiss National Science Foundation (PP00P3_194807). Swiss National Supercomputing Centre under project ID s1132. European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement no. 803952). Swiss National Science Foundation's Grant 320030-184807.Swiss National Science Foundation (grant number SCOPES IZ73Z0_152347/1) and National Academy of Sciences of Ukraine, project 'Molecular-Genetic Mechanisms of Human Disorders of Sexual Development' [0121U110054].
Data availability
All data generated during this study are included in the manuscript.
Article and author information
Author details
Ivan Domenech Mercadé
Funding
Maria de Maetzu Unit Excellence grants (MDM-2016-0687)
- James Castelli-Gair Hombría
Maria de Maetzu Unit Excellence grants (CEX-2020-001088-M)
- James Castelli-Gair Hombría
Ministerio de Ciencia, Innovación y Universidades (PID2019-104656GB-I00)
- James Castelli-Gair Hombría
Swiss National Science Foundation (PP00P3_194807)
- Stefano Vanni
Swiss National Supercomputing Center (s1132)
- Stefano Vanni
H2020 European Research Council (803952)
- Stefano Vanni
Swiss National Science Foundation (SCOPES IZ73Z0_152347/1)
- Ludmila Livshits
National Academy of Sciences of Ukraine (0121U110054)
- Ludmila Livshits
Swiss National Science Foundation (320030-184807)
- Anna Biason-Lauber
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Erika A Bach, New York University School of Medicine, United States
Ethics
Human subjects: All clinical investigations were performed according to the declaration of Helsinki principles. The study was approved by the Geneva ethical committee CCER, authorization number 14-121. The patients and/or their legal guardians gave informed written consent to the study.
Version history
- Preprint posted: August 1, 2022 (view preprint)
- Received: August 1, 2022
- Accepted: October 25, 2022
- Accepted Manuscript published: November 3, 2022 (version 1)
- Version of Record published: November 21, 2022 (version 2)
Copyright
© 2022, Sotillos et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 992
- views
-
- 118
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Human DLC3 and Drosophila Cv-c function in testis development: using a model organism to analyse variations in sex development
eLife 11:e82343.
https://doi.org/10.7554/eLife.82343
Further reading
-
- Developmental Biology
Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.
-
- Developmental Biology
- Structural Biology and Molecular Biophysics
The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.
